Jen L, PhD
@drjkyl.bsky.social
Executive Editor/Team Leader Open Access Science Journals Sage Publishing
Opinions = mine
http://linkedin.com/in/jlovick-editor
#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Opinions = mine
http://linkedin.com/in/jlovick-editor
#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Pinned
Jen L, PhD
@drjkyl.bsky.social
· Feb 21
Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️
Reposted by Jen L, PhD
How poor is the prognosis for dialysis-dependent #MultipleMyeloma? This multicenter study confirms it's severe, but also identifies a path to hope. Achieving dialysis independence TRIPLES median overall survival.
Key factors: VGPR, daratumumab, deep early light chain response.
Key factors: VGPR, daratumumab, deep early light chain response.
Dialysis dependence is associated with poor prognosis in multiple myeloma: a multicenter retrospective cohort study - Ji-nuo Wang, Chenyun Wang, Jinping Ying, Gaofeng Zheng, Xiaoyan Han, Peng An, Gang Wang, Fei Chen, Li Yang, Yang Yang, Donghua He, Jingsong He, Yuanshuai Chen, Wenjun Wu, Zhen Cai, 2025
Background: Patients with multiple myeloma (MM) and renal impairment (RI), particularly those requiring dialysis, have historically experienced poor outcomes. D...
buff.ly
November 10, 2025 at 8:15 AM
How poor is the prognosis for dialysis-dependent #MultipleMyeloma? This multicenter study confirms it's severe, but also identifies a path to hope. Achieving dialysis independence TRIPLES median overall survival.
Key factors: VGPR, daratumumab, deep early light chain response.
Key factors: VGPR, daratumumab, deep early light chain response.
Reposted by Jen L, PhD
Could the clock be a treatment factor? This retrospective study of 248 patients with mGC found better survival outcomes when nivolumab was infused before mid-afternoon.
Authors suggest infusion timing should be considered in daily practice. Details here: buff.ly/k54we7o
Authors suggest infusion timing should be considered in daily practice. Details here: buff.ly/k54we7o
November 10, 2025 at 9:21 AM
Could the clock be a treatment factor? This retrospective study of 248 patients with mGC found better survival outcomes when nivolumab was infused before mid-afternoon.
Authors suggest infusion timing should be considered in daily practice. Details here: buff.ly/k54we7o
Authors suggest infusion timing should be considered in daily practice. Details here: buff.ly/k54we7o
Reposted by Jen L, PhD
New Review online!
Here, Joost Smolders and colleagues argue that aggressive treatment of early acute focal inflammatory activity in #MultipleSclerosis can extend the window for BTK inhibition and slow down progression
journals.sagepub.com/doi/full/10....
Here, Joost Smolders and colleagues argue that aggressive treatment of early acute focal inflammatory activity in #MultipleSclerosis can extend the window for BTK inhibition and slow down progression
journals.sagepub.com/doi/full/10....
November 10, 2025 at 4:03 PM
New Review online!
Here, Joost Smolders and colleagues argue that aggressive treatment of early acute focal inflammatory activity in #MultipleSclerosis can extend the window for BTK inhibition and slow down progression
journals.sagepub.com/doi/full/10....
Here, Joost Smolders and colleagues argue that aggressive treatment of early acute focal inflammatory activity in #MultipleSclerosis can extend the window for BTK inhibition and slow down progression
journals.sagepub.com/doi/full/10....
Reposted by Jen L, PhD
Stem cell–based regeneration therapies in stress urinary incontinence: Mechanisms, innovation, and challenges
doi.org/10.1177/0963...
#stemcell #urinary
@journals.sagepub.com
doi.org/10.1177/0963...
#stemcell #urinary
@journals.sagepub.com
November 9, 2025 at 7:16 AM
Stem cell–based regeneration therapies in stress urinary incontinence: Mechanisms, innovation, and challenges
doi.org/10.1177/0963...
#stemcell #urinary
@journals.sagepub.com
doi.org/10.1177/0963...
#stemcell #urinary
@journals.sagepub.com
Reposted by Jen L, PhD
Age- and comorbidity-adjusted busulfan, fludarabine, cytarabine, and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation
doi.org/10.1177/0963...
doi.org/10.1177/0963...
November 9, 2025 at 7:24 AM
Age- and comorbidity-adjusted busulfan, fludarabine, cytarabine, and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation
doi.org/10.1177/0963...
doi.org/10.1177/0963...
Reposted by Jen L, PhD
Adipose-derived stem cells inhibit dendritic cell migration by secreting tumor necrosis factor-α-stimulated gene 6 to improve the allogeneic skin transplantation survival rate in mice
doi.org/10.1177/0963...
#stemcell #skin
doi.org/10.1177/0963...
#stemcell #skin
November 9, 2025 at 7:33 AM
Adipose-derived stem cells inhibit dendritic cell migration by secreting tumor necrosis factor-α-stimulated gene 6 to improve the allogeneic skin transplantation survival rate in mice
doi.org/10.1177/0963...
#stemcell #skin
doi.org/10.1177/0963...
#stemcell #skin
Phenotypic and functional comparisons between cryopreserved and freshly isolated peripheral blood mononuclear cells with or without red blood cell lysate (ACK) treatment with special focus on regulatory T cells
@celltransplant1992.bsky.social
@journals.sagepub.com
tinyurl.com/yc7edxas
#openaccess
@celltransplant1992.bsky.social
@journals.sagepub.com
tinyurl.com/yc7edxas
#openaccess
November 7, 2025 at 10:05 PM
Phenotypic and functional comparisons between cryopreserved and freshly isolated peripheral blood mononuclear cells with or without red blood cell lysate (ACK) treatment with special focus on regulatory T cells
@celltransplant1992.bsky.social
@journals.sagepub.com
tinyurl.com/yc7edxas
#openaccess
@celltransplant1992.bsky.social
@journals.sagepub.com
tinyurl.com/yc7edxas
#openaccess
Resistance mechanisms and therapeutic strategies for Pseudomonas aeruginosa infections
@tainfdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#antibioticresistance #infectiousdiseases #medicine #openaccess
@tainfdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#antibioticresistance #infectiousdiseases #medicine #openaccess
November 7, 2025 at 10:00 PM
Resistance mechanisms and therapeutic strategies for Pseudomonas aeruginosa infections
@tainfdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#antibioticresistance #infectiousdiseases #medicine #openaccess
@tainfdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#antibioticresistance #infectiousdiseases #medicine #openaccess
Comparison of the preventive effects of proton pump inhibitors and vonoprazan on delayed bleeding after gastric endoscopic submucosal dissection
@tagastroenterol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#gastriccancer #gastroenterology #healthcare #openaccess
@tagastroenterol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#gastriccancer #gastroenterology #healthcare #openaccess
November 7, 2025 at 9:58 PM
Comparison of the preventive effects of proton pump inhibitors and vonoprazan on delayed bleeding after gastric endoscopic submucosal dissection
@tagastroenterol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#gastriccancer #gastroenterology #healthcare #openaccess
@tagastroenterol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#gastriccancer #gastroenterology #healthcare #openaccess
Reposted by Jen L, PhD
New Review online!
Here, Wolfgang Jost and Jiri Koschel discuss approaches for diagnosing and treating cardiovascular symptoms in #Parkinson’s disease:
journals.sagepub.com/doi/full/10....
Here, Wolfgang Jost and Jiri Koschel discuss approaches for diagnosing and treating cardiovascular symptoms in #Parkinson’s disease:
journals.sagepub.com/doi/full/10....
November 6, 2025 at 10:42 AM
New Review online!
Here, Wolfgang Jost and Jiri Koschel discuss approaches for diagnosing and treating cardiovascular symptoms in #Parkinson’s disease:
journals.sagepub.com/doi/full/10....
Here, Wolfgang Jost and Jiri Koschel discuss approaches for diagnosing and treating cardiovascular symptoms in #Parkinson’s disease:
journals.sagepub.com/doi/full/10....
Reposted by Jen L, PhD
📢 Real-world data from China on T-DXd in HER2+ and HER2-low advanced breast cancer is here!
🧬 PFS ~10 months
📈 ORR: 62.5% (HER2+) | 37.9% (HER2-low)
✅ Manageable safety profile
T-DXd shows promise across HER2 expression levels. buff.ly/jrOE20b
#BreastCancer #HER2 #Oncology #RealWorldEvidence #TDXd
🧬 PFS ~10 months
📈 ORR: 62.5% (HER2+) | 37.9% (HER2-low)
✅ Manageable safety profile
T-DXd shows promise across HER2 expression levels. buff.ly/jrOE20b
#BreastCancer #HER2 #Oncology #RealWorldEvidence #TDXd
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
buff.ly
November 7, 2025 at 8:15 AM
📢 Real-world data from China on T-DXd in HER2+ and HER2-low advanced breast cancer is here!
🧬 PFS ~10 months
📈 ORR: 62.5% (HER2+) | 37.9% (HER2-low)
✅ Manageable safety profile
T-DXd shows promise across HER2 expression levels. buff.ly/jrOE20b
#BreastCancer #HER2 #Oncology #RealWorldEvidence #TDXd
🧬 PFS ~10 months
📈 ORR: 62.5% (HER2+) | 37.9% (HER2-low)
✅ Manageable safety profile
T-DXd shows promise across HER2 expression levels. buff.ly/jrOE20b
#BreastCancer #HER2 #Oncology #RealWorldEvidence #TDXd
Reposted by Jen L, PhD
🧬 Immunotherapy has transformed cancer care-but #prostatecancer remains resistant.
This review explores why traditional approaches fall short and highlights emerging strategies like: Checkpoint inhibitors; T-cell engagers; CAR-T cells
buff.ly/OV5DpZ2
#ProstateCancer #Immunotherapy #Oncology #CAR_T
This review explores why traditional approaches fall short and highlights emerging strategies like: Checkpoint inhibitors; T-cell engagers; CAR-T cells
buff.ly/OV5DpZ2
#ProstateCancer #Immunotherapy #Oncology #CAR_T
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 7, 2025 at 8:15 AM
🧬 Immunotherapy has transformed cancer care-but #prostatecancer remains resistant.
This review explores why traditional approaches fall short and highlights emerging strategies like: Checkpoint inhibitors; T-cell engagers; CAR-T cells
buff.ly/OV5DpZ2
#ProstateCancer #Immunotherapy #Oncology #CAR_T
This review explores why traditional approaches fall short and highlights emerging strategies like: Checkpoint inhibitors; T-cell engagers; CAR-T cells
buff.ly/OV5DpZ2
#ProstateCancer #Immunotherapy #Oncology #CAR_T
Reposted by Jen L, PhD
Elevated liver enzymes (AST, ALT, GGT) may correlate with lower #migraine prevalence—especially migraines without aura.
Could glutamate regulation be a metabolic clue in migraine pathology?
New study by Angela Ruban and colleagues:
journals.sagepub.com/doi/full/10....
Could glutamate regulation be a metabolic clue in migraine pathology?
New study by Angela Ruban and colleagues:
journals.sagepub.com/doi/full/10....
November 4, 2025 at 11:33 AM
Elevated liver enzymes (AST, ALT, GGT) may correlate with lower #migraine prevalence—especially migraines without aura.
Could glutamate regulation be a metabolic clue in migraine pathology?
New study by Angela Ruban and colleagues:
journals.sagepub.com/doi/full/10....
Could glutamate regulation be a metabolic clue in migraine pathology?
New study by Angela Ruban and colleagues:
journals.sagepub.com/doi/full/10....
Reposted by Jen L, PhD
🏠Can indoor radon affect lung cancer mutations? The RADON EUROPE study shows a link between high radon levels (>400 Bq/m³) and ALK rearrangements in NSCLC across 21 European countries.📍 This emphasizes the need for studying environmental impacts on cancer genomics. buff.ly/C3ktYC5 #LungCancer #NSCLC
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 5, 2025 at 8:15 AM
🏠Can indoor radon affect lung cancer mutations? The RADON EUROPE study shows a link between high radon levels (>400 Bq/m³) and ALK rearrangements in NSCLC across 21 European countries.📍 This emphasizes the need for studying environmental impacts on cancer genomics. buff.ly/C3ktYC5 #LungCancer #NSCLC
Reposted by Jen L, PhD
🧠 SCLC remains one of the most aggressive cancers.
This new review explores:
🔹 ICIs
🔹 Novel agents like lurbinectedin
🔹 Anti-DLL3 therapies
🔹 Molecular profiling for personalized care
buff.ly/Mmx2f1V
Hope is on the horizon for ES-SCLC.
#LungCancer #SCLC #Oncology #CancerResearch #Immunotherapy
This new review explores:
🔹 ICIs
🔹 Novel agents like lurbinectedin
🔹 Anti-DLL3 therapies
🔹 Molecular profiling for personalized care
buff.ly/Mmx2f1V
Hope is on the horizon for ES-SCLC.
#LungCancer #SCLC #Oncology #CancerResearch #Immunotherapy
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
buff.ly
November 5, 2025 at 8:15 AM
🧠 SCLC remains one of the most aggressive cancers.
This new review explores:
🔹 ICIs
🔹 Novel agents like lurbinectedin
🔹 Anti-DLL3 therapies
🔹 Molecular profiling for personalized care
buff.ly/Mmx2f1V
Hope is on the horizon for ES-SCLC.
#LungCancer #SCLC #Oncology #CancerResearch #Immunotherapy
This new review explores:
🔹 ICIs
🔹 Novel agents like lurbinectedin
🔹 Anti-DLL3 therapies
🔹 Molecular profiling for personalized care
buff.ly/Mmx2f1V
Hope is on the horizon for ES-SCLC.
#LungCancer #SCLC #Oncology #CancerResearch #Immunotherapy
Reposted by Jen L, PhD
🧠 20 years of #natalizumab in #MultipleSclerosis care:
A new Review reflects on two decades of clinical experience with natalizumab—its efficacy, safety, and evolving role in treatment strategies.
📖 Read this Open Access article here: doi.org/10.1177/1756...
A new Review reflects on two decades of clinical experience with natalizumab—its efficacy, safety, and evolving role in treatment strategies.
📖 Read this Open Access article here: doi.org/10.1177/1756...
November 5, 2025 at 11:18 AM
🧠 20 years of #natalizumab in #MultipleSclerosis care:
A new Review reflects on two decades of clinical experience with natalizumab—its efficacy, safety, and evolving role in treatment strategies.
📖 Read this Open Access article here: doi.org/10.1177/1756...
A new Review reflects on two decades of clinical experience with natalizumab—its efficacy, safety, and evolving role in treatment strategies.
📖 Read this Open Access article here: doi.org/10.1177/1756...
Reposted by Jen L, PhD
🚨 A multicenter study compares mFOLFOX-6 vs. mDCF in metastatic gastric & GEJ cancer. buff.ly/1NsLmel
🔍 Similar efficacy
📉 Lower toxicity with mFOLFOX-6
📊 493 patients across 25 hospitals
Is doublet chemo the new standard?
#GastricCancer #Oncology #GIcancer #Chemotherapy #CancerResearch
🔍 Similar efficacy
📉 Lower toxicity with mFOLFOX-6
📊 493 patients across 25 hospitals
Is doublet chemo the new standard?
#GastricCancer #Oncology #GIcancer #Chemotherapy #CancerResearch
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study - Ogur Karhan, Serdar İleri, Zuhat Urakçı, Yasin Sezgin, Ümit Yıldırım, Beyza Ünlü, Hacer Demir, Hasibe Bilge Gür, Ayşe Demirci, Melih Şimşek, Hüseyin Salih Semiz, Savaş Gökçek, Nilgün Yıldırım, Tuğçe Kübra Güneş, Abdilkerim Oyman, Tolga Doğan, Gamze Gököz Doğu, Yusuf İlhan, Özgür Tanrıverdi, Ali İnal, Nadiye Sever, Ezgi Türkoğlu, Tugay Avcı, Sadi Kerem Okutur, Pınar Peker, Doğan Bayram, Onur Yazdan Balçık, Pervin Can Şancı, Seray Saray, Pınar Çoban Eşdur, İsmail Beypınar, Sezai Tunç, 2025
Background: Metastatic gastric cancer (GC) and gastroesophageal junction (GEJ) cancer are associated with a poor prognosis. Recent advancements in treatment hav...
buff.ly
November 3, 2025 at 8:15 AM
🚨 A multicenter study compares mFOLFOX-6 vs. mDCF in metastatic gastric & GEJ cancer. buff.ly/1NsLmel
🔍 Similar efficacy
📉 Lower toxicity with mFOLFOX-6
📊 493 patients across 25 hospitals
Is doublet chemo the new standard?
#GastricCancer #Oncology #GIcancer #Chemotherapy #CancerResearch
🔍 Similar efficacy
📉 Lower toxicity with mFOLFOX-6
📊 493 patients across 25 hospitals
Is doublet chemo the new standard?
#GastricCancer #Oncology #GIcancer #Chemotherapy #CancerResearch
Reposted by Jen L, PhD
📢 Study on advanced #PancreaticCancer treatment reveals key survival factors: Only 8.3% of 204 patients lived beyond 2 years. ✅ Longer survival linked to good physical function (PS 0), low CRP & CA 19-9, high albumin, and peritoneal metastasis without fluid buildup.
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 3, 2025 at 8:15 AM
📢 Study on advanced #PancreaticCancer treatment reveals key survival factors: Only 8.3% of 204 patients lived beyond 2 years. ✅ Longer survival linked to good physical function (PS 0), low CRP & CA 19-9, high albumin, and peritoneal metastasis without fluid buildup.
Reposted by Jen L, PhD
💡 Editorial Review Board Member of the month - November 2025
This month, we interviewed Prof. Mohamed Roby, a Professor at the Food Science & Technology Department, Faculty of Agriculture, Fayoum University, Egypt.
Read more: journals.sagepub.com/page/npx/erb...
This month, we interviewed Prof. Mohamed Roby, a Professor at the Food Science & Technology Department, Faculty of Agriculture, Fayoum University, Egypt.
Read more: journals.sagepub.com/page/npx/erb...
November 3, 2025 at 12:07 PM
💡 Editorial Review Board Member of the month - November 2025
This month, we interviewed Prof. Mohamed Roby, a Professor at the Food Science & Technology Department, Faculty of Agriculture, Fayoum University, Egypt.
Read more: journals.sagepub.com/page/npx/erb...
This month, we interviewed Prof. Mohamed Roby, a Professor at the Food Science & Technology Department, Faculty of Agriculture, Fayoum University, Egypt.
Read more: journals.sagepub.com/page/npx/erb...
Reposted by Jen L, PhD
Optimistic bias related #Adherence of metastatic #BreastCancer patients to oral anticancer treatments: negative association between adherence rate and self-perception of treatment adherence. Personality matters: conscientiousness = risk awareness; extraversion = overconfidence. #Oncology
November 3, 2025 at 2:36 PM
Optimistic bias related #Adherence of metastatic #BreastCancer patients to oral anticancer treatments: negative association between adherence rate and self-perception of treatment adherence. Personality matters: conscientiousness = risk awareness; extraversion = overconfidence. #Oncology
Reposted by Jen L, PhD
Top Read Papers on Natural Product Communications - October 2025
💡 3. Unveiling the Antioxidant and AlphaAmylase Inhibitory Activity of Capparis spinosa L from Algeria:Synergistic Effects and Molecular Docking Insights. Bezghiche R, Kheddouma A, Douaouya L et al journals.sagepub.com/doi/10.1177/...
💡 3. Unveiling the Antioxidant and AlphaAmylase Inhibitory Activity of Capparis spinosa L from Algeria:Synergistic Effects and Molecular Docking Insights. Bezghiche R, Kheddouma A, Douaouya L et al journals.sagepub.com/doi/10.1177/...
November 3, 2025 at 4:26 PM
Top Read Papers on Natural Product Communications - October 2025
💡 3. Unveiling the Antioxidant and AlphaAmylase Inhibitory Activity of Capparis spinosa L from Algeria:Synergistic Effects and Molecular Docking Insights. Bezghiche R, Kheddouma A, Douaouya L et al journals.sagepub.com/doi/10.1177/...
💡 3. Unveiling the Antioxidant and AlphaAmylase Inhibitory Activity of Capparis spinosa L from Algeria:Synergistic Effects and Molecular Docking Insights. Bezghiche R, Kheddouma A, Douaouya L et al journals.sagepub.com/doi/10.1177/...
Reposted by Jen L, PhD
Novel entomo-virological tools, such as honey-baited traps preserving mosquito-expectorated RNA, are reshaping arbovirus monitoring. Integrating these with genomic surveillance can bridge field ecology and molecular epidemiology. 🔬🦟https://journals.sagepub.com/doi/full/10.1177/20499361251391261
November 2, 2025 at 5:05 PM
Novel entomo-virological tools, such as honey-baited traps preserving mosquito-expectorated RNA, are reshaping arbovirus monitoring. Integrating these with genomic surveillance can bridge field ecology and molecular epidemiology. 🔬🦟https://journals.sagepub.com/doi/full/10.1177/20499361251391261
Reposted by Jen L, PhD
📢 Call for Papers!
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World” buff.ly/ASkDwOt
🗓️ Join the conversation on cancer care for older adults.
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World” buff.ly/ASkDwOt
🗓️ Join the conversation on cancer care for older adults.
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
November 1, 2025 at 7:15 AM
📢 Call for Papers!
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World” buff.ly/ASkDwOt
🗓️ Join the conversation on cancer care for older adults.
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World” buff.ly/ASkDwOt
🗓️ Join the conversation on cancer care for older adults.
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Reposted by Jen L, PhD
📢 Call for Papers!
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World”
🗓️ Join the conversation on cancer care for older adults.
buff.ly/ASkDwOt
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World”
🗓️ Join the conversation on cancer care for older adults.
buff.ly/ASkDwOt
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
buff.ly
November 1, 2025 at 8:15 AM
📢 Call for Papers!
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World”
🗓️ Join the conversation on cancer care for older adults.
buff.ly/ASkDwOt
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Submit to our special issue: “Geriatric Oncology: Advancing Cancer Care in an Aging World”
🗓️ Join the conversation on cancer care for older adults.
buff.ly/ASkDwOt
#GeriatricOncology #CancerResearch #Oncology #CallForPapers #MedicalPublishing
Differential stress responses of immunoisolated human islets embedded in pancreatic extracellular matrix under static and free-fall dynamic conditions
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ERstress #ECM #diabetes #endocrinology #openaccess
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ERstress #ECM #diabetes #endocrinology #openaccess
October 31, 2025 at 9:37 PM
Differential stress responses of immunoisolated human islets embedded in pancreatic extracellular matrix under static and free-fall dynamic conditions
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ERstress #ECM #diabetes #endocrinology #openaccess
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ERstress #ECM #diabetes #endocrinology #openaccess